pharma news today obesity drugs glp-1 september 2025 Giants Bet on Next-Generation Treatments to Sustain Growth GLP-1 Drugs, Digital Health &

[DOI] [PMC free article] [PubMed] [Google Scholar] 8.Fras J

Sen S, Potnuru PP, Hernandez N, Goehl C, Praestholm C, Sridhar S, Nwokolo OO

Moreover, awareness about obesity as a disease and the rising adoption of obesity management programs have created immense potential for market expansion

It may happen when the dose is lowered, medication is paused, the body adapts, sleep worsens, stress increases, or old eating patterns return

These studies want to figure out exactly how it all works , which could lead to new advice about what to eat

[26] [27] Ultimately, treatment decisions should be made collaboratively, based on current evidence, regulatory approvals, and individualised assessment of benefits and risks